Carrie L. Bourdow's Net Worth
$789 Thousand
Who is Carrie L. Bourdow?
Carrie L. Bourdow does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include TREVENA INC, Sesen Bio, Inc., Nabriva Therapeutics plc, and Nabriva Therapeutics Plc.
SEC CIK
Carrie L. Bourdow's CIK is 0001638989
Past Insider Trading and Trends
2018 was Carrie L. Bourdow's most active year for acquiring shares with 6 total transactions. Carrie L. Bourdow's most active month to acquire stocks was the month of November. 2023 was Carrie L. Bourdow's most active year for disposing of shares, totalling 4 transactions. Carrie L. Bourdow's most active month to dispose stocks was the month of November. 2023 saw Carrie L. Bourdow paying a total of $286,700.00 for 570,000 shares, this is the most they've acquired in one year. In 2020 Carrie L. Bourdow cashed out on 284,618 shares for a total of $646,082.86, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
TREVENA INC (TRVN) Snapshot price: $0.5802
President & CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +257.09% | 462.88K |
$0.61 | $282,354.97 | 642.92K |
Dec 14
| |||
Form 4
| -6.26% | -12.03K |
$0.59 | -$7,096.52 | 180.05K |
Dec 2
| |||
Form 4
| +108.61% | 100K |
—
|
—
| 192.07K |
Jan 6
| |||
Form 4
| -1.44% | -1.34K |
$1.55 | -$2,080.10 | 92.07K |
Dec 17
| |||
Form 4
| -3.67% | -3.56K |
$3.42 | -$12,175.20 | 93.42K |
Dec 2
| |||
Form 4
| -1.36% | -33.55K |
$0.70 | -$23,482.20 | 2.42M |
Dec 17
| |||
Form 4
| -3.67% | -93.56K |
$0.65 | -$60,814.65 | 2.46M |
Dec 6
| |||
Form 4
| +96.04% | 1.25M |
—
|
—
| 2.55M |
Dec 2
| |||
Form 4
| +4.51% | 56.2K |
$1.79 | $100,541.80 | 1.3M |
Jun 28
| |||
Form 4/A
| -10.86% | -151.68K |
$2.27 | -$344,322.68 | 1.25M |
Dec 7
| |||
Form 4
| +59.41% | 471.1K |
—
|
—
| 1.26M |
Dec 17
| |||
Form 4
| -14.36% | -132.93K |
$2.27 | -$301,760.18 | 792.96K |
Dec 7
| |||
Form 4
| +244.33% | 657K |
—
|
—
| 925.89K |
Dec 12
| |||
Form 4
| -6.21% | -17.80K |
$0.69 | -$12,265.18 | 268.89K |
Dec 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 19
| |||
Form 4
| -5.85% | -17.80K |
$1.17 | -$20,828.34 | 286.7K |
Jun 3
| |||
Form 4
| +19.65% | 50K |
$1.02 | $51,000.00 | 304.5K |
Feb 1
| |||
Form 4
| +5,555.56% | 250K |
—
|
—
| 254.5K |
Dec 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 6
| |||
Form 4
| +800.00% | 4K |
$4.34 | $17,360.00 | 4.5K |
Nov 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Sesen Bio, Inc. (CARM) Snapshot price: $2
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 40K |
—
|
—
| 40K |
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Nabriva Therapeutics plc (NBRVF) Snapshot price: $0.000001
Director
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -46.23% | -8.54K |
$0.17 | -$1,486.81 | 9.93K |
Aug 1
| |||
Form 4
| -4.04% | -777.00 |
$1.20 | -$932.40 | 18.47K |
Aug 2
| |||
Form 4
| +1,000.00% | 17.5K |
—
|
—
| 19.25K |
Jul 28
| |||
Form 4
|
∞
| 17.5K |
—
|
—
| 17.5K |
Jul 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 31
| |||
| No matching records found | |||||||||
Nabriva Therapeutics Plc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||